Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial.
OBJECTIVE
To assess short-term efficacy of single intraarticular botulinum toxin (IA-BoNT/A) injection in patients with chronically painful total knee arthroplasty (TKA) in a randomized, placebo-controlled, triple-blind study.


METHODS
Patients with chronic TKA pain (pain > 6 on 0-10 scale and > 6 months post-TKA) evaluated in and referred from orthopedic surgery clinics were recruited. The primary outcome, proportion of patients with clinically meaningful decrease of at least 2 points on 0-10 visual analog scale (VAS) for pain, was compared between treatment groups at 2 months using comparison of proportions test and for all efficacy timepoints (2, 3, and 4 months) using generalized estimating equations (GEE). Secondary outcomes of global assessment, function, and quality of life were compared using GEE, duration of pain relief by t-test, and adverse events by chi-square test.


RESULTS
In total, 54 patients with 60 painful TKA were randomized, with main analyses restricted to one TKA per patient (49 TKA in 49 patients). Mean age was 67 years, 84% were men, and mean duration of TKA pain was 4.5 years. A significantly greater proportion of patients (71%) in the IA-BoNT/A group compared to IA-placebo (35%) achieved clinically meaningful reduction in VAS pain at 2 months (p = 0.028) and at all efficacy timepoints (p = 0.019). Duration of meaningful pain relief was significantly greater after IA-BoNT/A, 39.6 days (SD 50.4) compared to IA-placebo, 15.7 days (SD 22.6; p = 0.045). Statistically significantly better scores were seen in IA-BoNT/A vs IA-placebo for all efficacy timepoints for the following outcomes: "very much improved" on physician global assessment of change (p = 0.003); Western Ontario McMaster Osteoarthritis Index physical function (p = 0.026), stiffness (p = 0.004), and total scores (p = 0.024); and Short-Form 36 pain subscale score (p = 0.049). Number of total and serious adverse events was similar between groups, with no patients in either group with new objective motor or sensory deficits during followup.


CONCLUSIONS
In this single-center randomized trial, single IA-BoNT/A injection provided clinically meaningful short-term improvements in pain, global assessment, and function in patients with chronic painful TKA. A multicenter trial is needed to confirm these findings.
Singh
Jasvinder A
JA
Department of Medicine, Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota, USA. Jasvinder.md@gmail.com
Mahowald
Maren L
ML
Noorbaloochi
Siamak
S
D000368:Aged; D019645:Arthroplasty, Replacement, Knee; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D007270:Injections, Intra-Articular; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010149:Postoperative Pain / Q000628:therapy*; D018579:Patient Selection; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A
J Bone Joint Surg Br. 2001 Jan;83(1):69-74
11245541
Am J Epidemiol. 1996 Apr 15;143(8):757-65
8610685
J Clin Epidemiol. 1997 Mar;50(3):239-46
9120522
Rheumatology (Oxford). 2008 Dec;47(12):1792-4
18820311
Best Pract Res Clin Rheumatol. 2005 Jun;19(3):345-69
15939363
Pain. 1993 Apr;53(1):3-16
8316386
Clin Orthop Relat Res. 2003 Nov;(416):27-36
14646737
J Bone Joint Surg Br. 1997 Jan;79(1):114-6
9020458
Clin Orthop Relat Res. 2008 Nov;466(11):2717-23
18679762
Acad Emerg Med. 2001 Dec;8(12):1153-7
11733293
BMJ. 1998 Nov 7;317(7168):1292-6
9804720
Clin Orthop Relat Res. 2002 Aug;(401):125-31
12151889
BJU Int. 2009 Sep;104(5):657-61
19338543
BJU Int. 2008 Feb;101(3):366-70
18184328
Biochem Pharmacol. 2000 Jun 1;59(11):1403-6
10751549
J Am Geriatr Soc. 1991 Feb;39(2):142-8
1991946
Neurology. 2009 Apr 28;72(17):1473-8
19246421
J Rheumatol. 2002 Apr;29(4):783-6
11950022
J Rheumatol. 1988 Dec;15(12):1833-40
3068365
Arthritis Rheum. 2003 Mar;48(3):829-38
12632439
J Urol. 2006 Mar;175(3 Pt 1):1138-42
16469640
Joint Bone Spine. 2009 Mar;76(2):190-4
18952480
Arthritis Care Res. 2000 Oct;13(5):280-5
14635296
Eur J Pharmacol. 1998 Jun 5;350(2-3):181-8
9696406
J Rheumatol. 1993 Jan;20(1):21-7
8441160
Pain. 2000 Dec 1;88(3):287-294
11068116
Pain. 1987 Aug;30(2):191-197
3670870
Pain. 2000 Mar;85(1-2):101-5
10692608
J Rehabil Med. 2007 Jul;39(6):440-7
17624477
Int J Technol Assess Health Care. 2003 Winter;19(1):41-56
12701938
Neurology. 1990 Feb;40(2):277-80
2300249
Pain. 2004 Jan;107(1-2):125-33
14715398
Med Care. 1992 Jun;30(6):473-83
1593914
J Clin Rheumatol. 2009 Feb;15(1):35-8
19131763
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
17403800
Neurotox Res. 2006 Apr;9(2-3):179-88
16785116
Med Care. 1992 Oct;30(10):917-25
1405797
Br J Surg. 2008 Nov;95(11):1339-43
18844269
PM R. 2010 Apr;2(4):268-76
20430328
J Cell Sci. 2007 Aug 15;120(Pt 16):2864-74
17666428
Orthopedics. 2006 Feb;29(2):129-36; quiz 137-8
16485456
Pain. 2001 Nov;94(2):149-158
11690728
Spine (Phila Pa 1976). 1998 Aug 1;23(15):1662-6; discussion 1667
9704373
Osteoarthritis Cartilage. 2005 Feb;13(2):104-10
15694571
Ann Emerg Med. 2001 Dec;38(6):633-8
11719741
JAMA. 2003 Dec 17;290(23):3115-21
14679274
Cochrane Database Syst Rev. 2010 Sep 08;(9):CD008271
20824874
J Bone Joint Surg Br. 1998 Jan;80(1):151-5
9460973
Ann Rheum Dis. 2005 Jan;64(1):29-33
15208174
Nat Clin Pract Neurol. 2008 Dec;4(12):676-85
19043424
J Neurol. 2001 Apr;248 Suppl 1:34-8
11357239
Ann Neurol. 2008 Sep;64(3):274-83
18546285
Transl Res. 2009 May;153(5):205-16
19375681
Arthritis Rheum. 2003 Apr 15;49(2):156-63
12687505
J Bone Joint Surg Am. 2004 May;86(5):963-74
15118039
Neurosci Lett. 2008 Jun 6;437(3):199-202
18423863